Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spatial predictors of immunotherapy response in triple-negative breast cancer
Xiao Qian Wang, Esther Danenberg, Chiun‐Sheng Huang, et al.
Nature (2023) Vol. 621, Iss. 7980, pp. 868-876
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Decoding the tumor microenvironment with spatial technologies
Logan A. Walsh, Daniela F. Quail
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1982-1993
Closed Access | Times Cited: 50
Open-ST: High-resolution spatial transcriptomics in 3D
Marie Schott, Daniel León-Periñán, Elena Splendiani, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3953-3972.e26
Open Access | Times Cited: 25
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer
Lenka Kašíková, Jana Raková, Michal Hensler, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
Katey S.S. Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1018-1047
Open Access | Times Cited: 22
Towards targeting the breast cancer immune microenvironment
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 22
Multiplex protein imaging in tumour biology
Natalie de Souza, Shan Zhao, Bernd Bodenmiller
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 171-191
Closed Access | Times Cited: 19
Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
Gunsagar S. Gulati, Jeremy Philip D’Silva, Yunhe Liu, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 26, Iss. 1, pp. 11-31
Closed Access | Times Cited: 16
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 14
Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system
Philipp Schäfer, Daniel Dimitrov, Eduardo J. Villablanca, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 405-417
Closed Access | Times Cited: 12
A Programmable Peptidic Hydrogel Adjuvant for Personalized Immunotherapy in Resected Stage Tumors
Bihan Wu, Juan Liang, Xuejiao Yang, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 12, pp. 8585-8597
Closed Access | Times Cited: 12
Spatiotemporal omics for biology and medicine
Longqi Liu, Ao Chen, Yuxiang Li, et al.
Cell (2024) Vol. 187, Iss. 17, pp. 4488-4519
Closed Access | Times Cited: 12
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer
Jean Abraham, Karen Pinilla, Alimu Dayimu, et al.
Nature (2024) Vol. 629, Iss. 8014, pp. 1142-1148
Open Access | Times Cited: 10
Spatial landscapes of cancers: insights and opportunities
Julia Chen, Ludvig Larsson, Alexander Swarbrick, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 660-674
Closed Access | Times Cited: 10
Systemic and local immunosuppression in glioblastoma and its prognostic significance
Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
The characterization of tumor immune microenvironment after neoadjuvant immunotherapy in head and neck squamous cell cancer using multiplex immunohistochemistry
Zhaohong An, Xiwei Zhang, Zhaoyang Wang, et al.
Oral Oncology (2025) Vol. 161, pp. 107151-107151
Closed Access
Cytotoxic and regulatory T cell interactions calculated from image mass cytometry predict immunochemotherapy response in triple‐negative breast cancer
Xiang Wang, Jing Dong, Jianrong Li, et al.
Cancer Communications (2025)
Open Access
The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
Yi Yao, Yu Zhong, Lu Xie, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access
Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer
Binyu Zhu, Ying Cai, Lingli Zhou, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges
Ilana Schlam, Sherene Loi, Roberto Salgado, et al.
ESMO Open (2025) Vol. 10, Iss. 2, pp. 104120-104120
Closed Access
The XCL1–XCR1 axis supports intestinal tissue residency and antitumor immunity
Amir Ferry, K Mempel, Alexander Monell, et al.
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 2
Closed Access
TNIP1 Impacts Prognosis by Modulating the Immune Microenvironment in BRCA
Dong Liao, Wu Liu, Yunhui Jiang, et al.
Biochemical Genetics (2025)
Closed Access
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
Yuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Cancer Cell (2025)
Open Access
Bi-level graph learning unveils prognosis-relevant tumor microenvironment patterns in breast multiplexed digital pathology
Zhenzhen Wang, Cesar A. Santa‐Maria, Aleksander S. Popel, et al.
Patterns (2025), pp. 101178-101178
Open Access
Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer
Michele Bottosso, F. Mosele, Stefan Michiels, et al.
ESMO Open (2024) Vol. 9, Iss. 3, pp. 102247-102247
Open Access | Times Cited: 5
Use of Pretreatment Perfusion MRI–based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant Chemoimmunotherapy
Toulsie Ramtohul, Victoire Lepagney, Claire Bonneau, et al.
Radiology (2024) Vol. 312, Iss. 3
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top